Hospitalized poisonings after renal transplantation in the United States

Abstract

Background: The national incidence of and risk factors for hospitalized poisonings in renal transplant recipients has not been reported.

Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel

“…18,30,31 Insulin-related medication errors occur in all hospital settings, including but not limited to the emergency department, critical care units, medical-surgical units, and the perioperative setting. 11,25,[32][33][34][35] In addition, insulin is frequently implicated in adverse drug events detected in patients who present to the emergency department. 36 Given the incidence of insulinrelated medication errors in hospitals, the American Society of Health-System Pharmacists (ASHP) Research and Education Foundation convened a multidisciplinary expert panel to develop expert consensus recommendations to promote best practices to further enhance the safe use of insulin in the inpatient setting.…”

Development of a Predictive Model for Drug‐Related Problems in Kidney Transplant Recipients

“…Transplant recipients are inherently at high risk for DRPs given the complexity of their medication regimens, multiple comorbid conditions, and use of narrow–therapeutic index medications. Despite the propensity for DRPs, there is a scarcity of published literature regarding the incidence, risk factors, and effects of DRPs in renal transplant recipients . The literature that does exist in renal transplant patients, as well as data extrapolated from the surgical population, suggests that DRPs in this population have been associated with an increased risk of infection, rejection, and graft loss …”

“…Despite the propensity for DRPs, there is a scarcity of published literature regarding the incidence, risk factors, and effects of DRPs in renal transplant recipients. 4,5 The literature that does exist in renal transplant patients, as well as data extrapolated from the surgical population, suggests that DRPs in this population have been associated with an increased risk of infection, rejection, and graft loss. [6][7][8][9] Pharmacists are uniquely equipped to identify DRPs, and their positive impact on intervening on behalf of patients with DRPs and reducing rates of DRPs has been demonstrated in numerous populations.…”

Medication Errors and Adverse Drug Events in Kidney Transplant Recipients: Incidence, Risk Factors, and Clinical Outcomes

“…Despite kidney transplant recipients having characteristics that put them at high risk for medication‐related problems (MRPs), including numerous drug changes while hospitalized, advanced age, and use of drugs with a narrow therapeutic index, publications addressing overall incidence, risk factors, outcomes, and prevention strategies of patient‐induced medication errors and associated ADEs are severely limited or lacking altogether . Based on studies conducted in generalized hospitalized patients, as well as in patients in the ambulatory setting after recent hospitalization, it is likely that MRPs are a frequent occurrence for kidney transplant recipients and potentially contribute to suboptimal short‐ and long‐term graft and patient outcomes …”